Mitesco (OTCMKTS:MITI) and American Well (NYSE:AMWL) Financial Analysis

Mitesco (OTCMKTS:MITIGet Free Report) and American Well (NYSE:AMWLGet Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.

Earnings & Valuation

This table compares Mitesco and American Well”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mitesco $40,000.00 31.31 $500,000.00 ($0.36) -0.17
American Well $249.32 million 0.52 -$95.70 million ($5.42) -1.44

Mitesco has higher earnings, but lower revenue than American Well. American Well is trading at a lower price-to-earnings ratio than Mitesco, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and target prices for Mitesco and American Well, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mitesco 0 0 0 0 0.00
American Well 1 4 1 0 2.00

American Well has a consensus price target of $7.30, indicating a potential downside of 6.53%. Given American Well’s stronger consensus rating and higher possible upside, analysts plainly believe American Well is more favorable than Mitesco.

Profitability

This table compares Mitesco and American Well’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mitesco -7,638.20% -2.18% 303.55%
American Well -37.02% -32.11% -24.12%

Volatility and Risk

Mitesco has a beta of 4.97, suggesting that its share price is 397% more volatile than the S&P 500. Comparatively, American Well has a beta of 1.52, suggesting that its share price is 52% more volatile than the S&P 500.

Insider & Institutional Ownership

0.0% of Mitesco shares are owned by institutional investors. Comparatively, 56.1% of American Well shares are owned by institutional investors. 4.9% of Mitesco shares are owned by company insiders. Comparatively, 12.8% of American Well shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

About Mitesco

(Get Free Report)

Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.

About American Well

(Get Free Report)

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Receive News & Ratings for Mitesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mitesco and related companies with MarketBeat.com's FREE daily email newsletter.